首页> 外文OA文献 >Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.

【2h】

Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.

机译：用胰高血糖素样肽-1（GLp-1）受体激动剂利拉鲁肽长期治疗对两种转基因app / ps1小鼠阿尔茨海默病模型中的β-淀粉样蛋白斑块负荷没有影响。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Henrik H Hansen; Katrine Fabricius; Pernille Barkholt; Pernille Kongsbak-Wismann; Chantal Schlumberger; Jacob Jelsing; Dick Terwel; Annelies Termont; Charles Pyke; Lotte Bjerre Knudsen; Niels Vrang;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease [J] . Jingjing Tai, Weizhen Liu, Yanwei Li, Brain research . 2018,第期

机译：三重GLP-1 / GIP / Glucagon受体激动剂在Alzheimer疾病的APP / PS1转基因小鼠模型中的神经保护作用
2. Coenzyme Q10 reduces beta-amyloid plaque in an APP/PS1 transgenic mouse model of Alzheimer's disease. [J] . Yang X, Dai G, Li G, Journal of Molecular Neuroscience: MN . 2010,第1期

机译：辅酶Q10减少了阿尔茨海默氏病APP / PS1转基因小鼠模型中的β-淀粉样蛋白斑块。
3. Treatment with an amyloid-beta antibody ameliorates plaque load, learning deficits, and hippocampal long-term potentiation in a mouse model of Alzheimer's disease. [J] . Hartman RE, Izumi Y, Bales KR, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience . 2005,第26期

机译：使用淀粉样β抗体治疗可改善阿尔茨海默氏病小鼠模型中的斑块负荷，学习缺陷和海马长期增强作用。
4. Type Ⅱ Fuzzy Systems for Amyloid Plaque Segmentation in Transgenic Mouse Brains for Alzheimer's Disease Quantification [C] . April Khademi, Danoush Hosseinzadeh Conference on digital pathology . 2014

机译：用于阿尔茨海默氏病定量的转基因小鼠脑中淀粉样蛋白斑块分割的Ⅱ型模糊系统
5. Magnetic resonance imaging and histological analysis of beta-amyloid plaques in human Alzheimer's disease and APP/PS1 transgenic mice [D] . Meadowcroft, Mark David 2009

机译：人阿尔茨海默氏病和APP / PS1转基因小鼠中β淀粉样蛋白斑的磁共振成像和组织学分析
6. Long-Term Treatment with Liraglutide a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer’s Disease [O] . Henrik H. Hansen, Katrine Fabricius, Pernille Barkholt, -1

机译：长期使用利拉鲁肽（一种胰高血糖素样肽-1（GLP-1）受体激动剂）对两种阿尔茨海默氏病转基因APP / PS1小鼠模型的β-淀粉样蛋白斑块负荷没有影响
7. Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease [O] . Jingjing Tai, Weizhen Liu, Yanwei Li, 2018

机译：三重GLP-1 / GIP / Glucagrag毒剂激动剂在Alzheimer疾病的APP / PS1转基因小鼠模型中的神经保护作用

Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.

著录项

相似文献

相关主题

期刊订阅